Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort

AIMS: The introduction of non-VKA oral anticoagulants (NOACs), which differ from the earlier vitamin K antagonist (VKA) treatments, has changed the approach to stroke prevention in atrial fibrillation (AF). GLORIA-AF is a prospective, global registry programme describing the selection of antithrombo...

Descripción completa

Detalles Bibliográficos
Autores principales: Huisman, Menno V., Ma, Chang Sheng, Diener, Hans-Christoph, Dubner, Sergio J., Halperin, Jonathan L., Rothman, Kenneth J., Teutsch, Christine, Schoof, Nils, Kleine, Eva, Bartels, Dorothee B., Lip, Gregory Y.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006962/
https://www.ncbi.nlm.nih.gov/pubmed/27335063
http://dx.doi.org/10.1093/europace/euw073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006962/
https://www.ncbi.nlm.nih.gov/pubmed/27335063
http://dx.doi.org/10.1093/europace/euw073

Ejemplares similares